Ixico news

30 Apr 2015 Brain health company IXICO today (30 April 2015) launched a digital platform, Project Cygnus, and MyBrainBook®, IXICO's digital dementia diagnosis and patient support platform. News Releases 2 March 2020  5 Jul 2017 Neuroscience-focused digital technology company Ixico just nabbed a contract Subscribe to FierceBiotech to get industry news and updates  IXICO's compliant image and digital data management, provides all you need to manage the complex data workflows that come with many clinical trials. IXICO also offers a secure online digital platform as an enabler of clinical decision support for patient selection and post-marketing surveillance.

Ixico joins Alzheimer's disease research initiative Sharecast News, 03 Feb. Director dealings: Ixico CEO ups stake Sharecast News, 23 Jan. Ixico announces   IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral  IXI | Complete Ixico PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The latest news from the world of business and finance for growth companies. Praseeda Nair. IXICO, a spin-out company from London University, has drummed   Welcome to the Stockopedia community's LON:IXI discussion board, with posts on IXICO share news, analysis and share sentiment. Register for an account to  4 Dec 2018 Provides a solid foundation for continued growth momentum. IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience,  5 Mar 2019 Neuroimaging analytics company IXICO has teamed up with the London Medical Imaging & Artificial Intelligence Centre, the newly open £10m 

View the latest share news for IXICO and LON:IXI RNS announcements, along with all the share chat by members of the Stockopedia community

Welcome to the Stockopedia community's LON:IXI discussion board, with posts on IXICO share news, analysis and share sentiment. Register for an account to  4 Dec 2018 Provides a solid foundation for continued growth momentum. IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience,  5 Mar 2019 Neuroimaging analytics company IXICO has teamed up with the London Medical Imaging & Artificial Intelligence Centre, the newly open £10m  12 Dec 2013 IXICO plc and Beijing Union Medical have signed an MoU to jointly and technology magazine that highlights R&D news stories from Asia to a  18 Nov 2015 UK-based brain health company Ixico has entered into an acquisition agreement to conditionally acquire Optimal Medicine. 24 Sep 2013 The enlarged group will be called Ixico and will begin trading on Aim The news will be welcomed by shareholders who have suffered after  26 Jul 2019 2019-07-26 News. What is your current role in EPAD? I am a Project Manager at IXICO plc, and I manage the delivery of Magnetic Resonance 

5 Jul 2017 Neuroscience-focused digital technology company Ixico just nabbed a contract Subscribe to FierceBiotech to get industry news and updates 

8 million extension to a Phase III study in Huntington's Disease (HD), previously announced in September 2018 - £0. Read more. Category: Financial News  News Results for IXICO (IXI). Price: 54.00p -3.00 (-5.26%) Bid: 53.00p Ask: 55.00 p Spread: 3.64%. 23 Jan 09:00. Director Deals - IXICO plc (IXI). Giulio Cerroni  IXICO PLC (LON:IXI) Share Price and News. IXICO's purpose is to advance medicine and human health by turning data into clinically meaningful information,   Ixico Share Chat - IXI Ixico Share Discussion Threads. Next Page 19/2/2020 13:32, halfpenny: IXI should have some great contract news flow.

IXICO plc is a UK clinical research firm that provides neuroimaging and digital biomarker "Phytopharm suspends shares pending acquisition | Business Weekly | Technology News | Business news | Cambridge and the East of England".

Description. IXICO's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in  The latest Tweets from IXICO (@IXICOnews). Advanced Analytics. Intelligent Insights. London, UK. Ixico joins Alzheimer's disease research initiative Sharecast News, 03 Feb. Director dealings: Ixico CEO ups stake Sharecast News, 23 Jan. Ixico announces   IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral  IXI | Complete Ixico PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The latest news from the world of business and finance for growth companies. Praseeda Nair. IXICO, a spin-out company from London University, has drummed   Welcome to the Stockopedia community's LON:IXI discussion board, with posts on IXICO share news, analysis and share sentiment. Register for an account to 

Ixico joins Alzheimer's disease research initiative 3 February 2020 14:05 (Sharecast News) - Artificial intelligence data analytics company Ixico announced funding support for the Alzheimer's

4 Dec 2018 Provides a solid foundation for continued growth momentum. IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience,  5 Mar 2019 Neuroimaging analytics company IXICO has teamed up with the London Medical Imaging & Artificial Intelligence Centre, the newly open £10m  12 Dec 2013 IXICO plc and Beijing Union Medical have signed an MoU to jointly and technology magazine that highlights R&D news stories from Asia to a  18 Nov 2015 UK-based brain health company Ixico has entered into an acquisition agreement to conditionally acquire Optimal Medicine. 24 Sep 2013 The enlarged group will be called Ixico and will begin trading on Aim The news will be welcomed by shareholders who have suffered after  26 Jul 2019 2019-07-26 News. What is your current role in EPAD? I am a Project Manager at IXICO plc, and I manage the delivery of Magnetic Resonance  30 Apr 2015 Brain health company IXICO today (30 April 2015) launched a digital platform, Project Cygnus, and MyBrainBook®, IXICO's digital dementia diagnosis and patient support platform. News Releases 2 March 2020 

AAT-AD/PD™ focus meeting - Virtual conference. The AAT-AD/PD™ Focus Meeting 2020 will present all the latest breakthroughs in treatment, translational R&D  8 million extension to a Phase III study in Huntington's Disease (HD), previously announced in September 2018 - £0. Read more. Category: Financial News  News Results for IXICO (IXI). Price: 54.00p -3.00 (-5.26%) Bid: 53.00p Ask: 55.00 p Spread: 3.64%. 23 Jan 09:00. Director Deals - IXICO plc (IXI). Giulio Cerroni